The company has its head office and manufacturing in
The healthcare & medical market is expected to report stable and strong growth in the years ahead. For Trelleborg, the bolt-on acquisition is part of its strategy to grow in attractive industries that have high entry barriers, and which complement and strengthen its existing offerings.
"EirMed is a welcome addition in our process of building a larger and more complete offering in healthcare & medical. The market for technical polymer-based precision components is a strategically important area for us. The acquisition gives us access to new markets, applications and customers, while EirMed's solutions will gain access to our broad sales channels. The company also has exciting development projects in bioresorbable polymers," says
The ongoing macro trends in healthcare & medical, such as an aging population and a growing global middle class, are driving higher technological content in both health and medical care, as well as the medtech industry.
The transaction is consolidated as of
For further information, please contact:
Media: Vice President Communications
Investors/analysts: Vice President IR Christofer Sjögren, +46 (0)410 67068, +46 (0)708 665140, christofer.sjogren@trelleborg.com
Trelleborg is a world leader in engineered polymer solutions that seal, damp and protect critical applications in demanding environments. Its innovative solutions accelerate performance for customers in a sustainable way.
www.trelleborg.com
https://news.cision.com/trelleborg/r/trelleborg-acquires-us-healthcare---medical-company,c3552513
https://mb.cision.com/Main/584/3552513/1568923.pdf
(c) 2022 Cision. All rights reserved., source